Predictors of resistance to abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer in post-docetaxel setting: a single-center cohort study

Single Center ◽

A transcriptome analysis of castration resistant prostate cancer metastases in a prospective cohort study reveals high expression of AKT pathway genes predictive of long term response to abiraterone acetate/prednisone.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.5038 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 5038-5038 ◽

Cited By ~ 1

Author(s):

Manish Kohli ◽

Scott Dehm ◽

Vipul Bhargava ◽

Michael Gormley ◽

Jason P. Sinnwell ◽

...

Keyword(s):

Prostate Cancer ◽

Cohort Study ◽

Transcriptome Analysis ◽

Abiraterone Acetate ◽

Akt Pathway ◽

Castration Resistant ◽

Cancer Metastases ◽

Term Response

A single-center experience with abiraterone acetate in metastatic castration resistant prostate cancer

European Urology Supplements ◽

10.1016/s1569-9056(18)33741-2 ◽

2018 ◽

Vol 17 (14) ◽

pp. e2872

Author(s):

A. Afonso ◽

S. Coelho ◽

M. Fontes ◽

M.J. Maurício

Keyword(s):

Prostate Cancer ◽

Abiraterone Acetate ◽

Single Center ◽

Single Center Experience ◽

Abiraterone acetate plus prednisone for the Management of Metastatic Castration-Resistant Prostate Cancer (mCRPC) without prior use of chemotherapy: report from a large, international, real-world retrospective cohort study

BMC Cancer ◽

10.1186/s12885-019-5280-6 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 14

Author(s):

Martin Boegemann ◽

Sara Khaksar ◽

Guillaume Bera ◽

Alison Birtle ◽

Catherine Dopchie ◽

...

Keyword(s):

Prostate Cancer ◽

Cohort Study ◽

Real World ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Prior Use

177lutetium-Prostate-Specific Membrane Antigen Radionuclide Therapy of Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Single Center Cohort Study

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2019.06.1871 ◽

2019 ◽

Vol 105 (1) ◽

pp. E263

Author(s):

R. Baum ◽

F. Von Eyben ◽

A. Singh ◽

J. Zhang ◽

K. Nipsch ◽

...

Keyword(s):

Prostate Cancer ◽

Cohort Study ◽

Radionuclide Therapy ◽

Prostate Specific Membrane Antigen ◽

Single Center ◽

Castration Resistant ◽

Specific Membrane

Abiraterone Acetate and Enzalutamide: Similar Efficacy in Treating Post Docetaxel Metastatic Castration-resistant Prostate Cancer: Single Center Experience

Anticancer Research ◽

10.21873/anticanres.13541 ◽

2019 ◽

Vol 39 (7) ◽

pp. 3901-3908

Author(s):

LI-WEN CHANG ◽

SHENG-CHUN HUNG ◽

SHIAN-SHIANG WANG ◽

JIAN-RI LI ◽

CHENG-KUANG YANG ◽

...

Keyword(s):

Prostate Cancer ◽

Similar Efficacy ◽

Abiraterone Acetate ◽

Single Center ◽

Single Center Experience ◽

18F-fluciclovine PET in Metastatic Castration Resistant Prostate Cancer Treated With Abiraterone Acetate

Case Medical Research ◽

10.31525/ct1-nct04158245 ◽

2019 ◽

Author(s):

Keyword(s):

Prostate Cancer ◽

Abiraterone Acetate ◽

Faculty Opinions recommendation of Phase I clinical trial of a selective inhibitor of CYP17, abiraterone acetate, confirms that castration-resistant prostate cancer commonly remains hormone driven.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1118816.793494158 ◽

2014 ◽

Author(s):

Thomas Flaig

Keyword(s):

Prostate Cancer ◽

Clinical Trial ◽

Phase I ◽

Abiraterone Acetate ◽

Selective Inhibitor ◽

Phase I Clinical Trial ◽

Faculty Opinions recommendation of Antitumour activity of abiraterone acetate against metastatic castration-resistant prostate cancer progressing after docetaxel and enzalutamide (MDV3100).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717999366.793474668 ◽

2013 ◽

Author(s):

Michael Glode

Keyword(s):

Prostate Cancer ◽

Antitumour Activity ◽

Abiraterone Acetate ◽

A Rapid, Direct and Validated HPLC- Fluorescence Method for the Quantification of Abiraterone and Abiraterone Acetate in Urine and Serum Samples from Patients with Castration- Resistant Prostate Cancer

Current Pharmaceutical Analysis ◽

10.2174/1573412913666170213152002 ◽

2018 ◽

Vol 14 (3) ◽

pp. 233-238 ◽

Cited By ~ 1

Author(s):

Juana Rodriguez ◽

Gregorio Castaneda ◽

Isabel Lizcano ◽

Jose C. Villa

Keyword(s):

Prostate Cancer ◽

Abiraterone Acetate ◽

Fluorescence Method ◽

Serum Samples ◽

Castration Resistant ◽

Urine And Serum

Medication patterns of abiraterone acetate plus prednisone or enzalutamide and PSA progression in veterans with metastatic castration-resistant prostate cancer

Current Medical Research and Opinion ◽

10.1080/03007995.2021.1888704 ◽

2021 ◽

Vol 37 (4) ◽

pp. 635-642

Author(s):

Stephen J. Freedland ◽

Sophia Li ◽

Dominic Pilon ◽

Rachel H. Bhak ◽

Sahil Narkhede ◽

...

Keyword(s):

Prostate Cancer ◽

Abiraterone Acetate ◽

Castration Resistant ◽

Psa Progression